Detalhe da pesquisa
1.
Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study.
J Pediatr
; 253: 189-196.e2, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181868
2.
Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage.
J Pediatr
; 244: 178-185.e3, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031347
3.
Global scientific production in the pre-Covid-19 Era: An analysis of 53 countries for 22 years.
An Acad Bras Cienc
; 94(suppl 3): e20201428, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417599
4.
COVID-19 pandemic and the answer of science: a year in review.
An Acad Bras Cienc
; 93(4): e20210543, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495206
5.
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years.
World J Pediatr
; 19(10): 949-960, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914907
6.
Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database.
Lancet Child Adolesc Health
; 5(8): 559-568, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119027
7.
Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents.
Pediatr Infect Dis J
; 42(3): 218-225, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730085
8.
Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil - Authors' reply.
Lancet Child Adolesc Health
; 5(10): e40-e42, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536362